Our capital markets team has advised AIM quoted biopesticides product and technology company, Eden Research, in relation to its secondary capital fundraising of up to £11 million through a firm placing, conditional placing, subscription and retail offer, with Cenkos Securities plc acting as bookrunner and broker.

Eden Research is an Oxfordshire-based company focused on developing sustainable biopesticides and plastic-free formulation technology for use in the global crop protection, animal health and consumer products industries. Eden Research is currently the only UK-quoted company focused on biopesticides for sustainable agriculture and is well positioned to capitalise on the rapidly growing biopesticides market, which is projected to be worth over £11 billion by 2027.

Principal associate in Gowling WLG's capital markets team, Alex Davidson, led on the fundraising, supported by corporate partner David Brennan, legal director Sue Johnston and trainee Nimmi Joseph.

Commenting on the fundraise, Alex Davidson said:

"We are delighted to have assisted Eden Research in completing such a successful fundraise, especially in such a challenging market. We look forward to seeing Eden Research build on its existing success."